Foundations Investment Advisors’s iShares 5-10 Year Investment Grade Corporate Bond ETF IGIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Buy
+4,737
New +$255K ﹤0.01% 981
2025
Q1
Sell
-4,006
Closed -$206K 892
2024
Q4
$206K Buy
4,006
+49
+1% +$2.57K ﹤0.01% 800
2024
Q3
$213K Sell
3,957
-1,454
-27% -$76.7K ﹤0.01% 755
2024
Q2
$277K Buy
5,411
+855
+19% +$43.5K 0.01% 628
2024
Q1
$235K Buy
+4,556
New +$234K 0.01% 637

Other funds holding IGIB

Foundations Investment Advisors's IGIB Position: Q1 2026 in Review

Foundations Investment Advisors opened a new position in iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) in Q1 2026: 4,737 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #981 among its holdings. This is a return to the name: Foundations Investment Advisors previously reported a position in IGIB as recently as Q4 2024.

Foundations Investment Advisors first reported a position in IGIB in Q1 2024 and has held it in 5 quarters since. The position peaked at $277K in Q2 2024. 705 funds tracked by Wall St. Rank hold IGIB as of Q1 2026.

  • Foundations Investment Advisors held 4,737 shares of iShares 5-10 Year Investment Grade Corporate Bond ETF worth $252K as of Q1 2026.
  • iShares 5-10 Year Investment Grade Corporate Bond ETF was a new Foundations Investment Advisors position in Q1 2026.
  • iShares 5-10 Year Investment Grade Corporate Bond ETF made up ﹤0.01% of Foundations Investment Advisors's portfolio in Q1 2026, its #981 holding.
  • Foundations Investment Advisors first reported a position in iShares 5-10 Year Investment Grade Corporate Bond ETF in Q1 2024 and has held it in 5 quarters since.
  • Foundations Investment Advisors's iShares 5-10 Year Investment Grade Corporate Bond ETF position peaked at $277K in Q2 2024.
  • 705 funds tracked by Wall St. Rank held iShares 5-10 Year Investment Grade Corporate Bond ETF as of Q1 2026.

Based on Foundations Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.